NCT00201656

Brief Summary

The purpose of this study is to determine whether retention of cervical cerclage after PPROM improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Nov 2004

Longer than P75 for phase_4

Geographic Reach
1 country

23 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2004

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 20, 2005

Completed
8.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

December 19, 2014

Status Verified

December 1, 2014

Enrollment Period

9 years

First QC Date

September 13, 2005

Last Update Submit

December 17, 2014

Conditions

Keywords

PPROMCerclagePreterm Premature Rupture of the Membranes with Cerclage

Outcome Measures

Primary Outcomes (12)

  • Chorioamnionitis as defined by temperature > 38 plus fetal tachycardia or uterine tenderness

    conception to birth

  • Composite neonatal outcome - any one of the following (for twins, either infant): Fetal or neonatal death

    Birth to 28days of life

  • Respiratory distress syndrome

    birth to 28days of life

  • Documented sepsis within 72 hours of delivery

    birth to 72 hours after delivery

  • Grade 3 or 4 intraventricular hemorrhage

    birth to 28days of life

  • Stage 2 or 3 necrotizing enterocolitis

    birth to 28days of life

  • Neonatal intensive care unit (NICU) stay

    birth to 28days of life

  • Birth weight

    at birth

  • Estimated gestational age (EGA) at delivery

    at delivery

  • Postpartum endometritis

    birth to 28days of life

  • Maternal sepsis

    birth to 28days following delivery

  • Latency

    labor to delivery

Study Arms (2)

1 Retention of Cerclage

ACTIVE COMPARATOR

Group one = Subject whose Cerclage is retained after randomization.

Procedure: Retention of CerclageProcedure: Removal vs. Retention of Cervical Cerclage

2 - Removal of Cerclage

ACTIVE COMPARATOR

Group 2 = Subjects who will have cerclage removed after randomization

Procedure: Removal of CerclageProcedure: Removal vs. Retention of Cervical Cerclage

Interventions

Retain Cerclage until clinical removal is indicated by protocol

1 Retention of Cerclage

Immediate removal of Cerclage following randomization

2 - Removal of Cerclage

Immediate removal of cerclage following randomization vs. retention of cerclage until labor, chorioamnionitis, or fetal distress

Also known as: McDonald or Shirodkar Cerclage
1 Retention of Cerclage2 - Removal of Cerclage

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • A previously placed prophylactic cerclage defined as any cerclage done \< 23 6/7 weeks including those done for previous history of cervical incompetence, asymptomatic cervical shortening (regardless of effacement) and asymptomatic cervical dilation \< 3 cm
  • Spontaneous rupture of membranes 22-32 weeks
  • Singleton or twin gestation
  • Shirodkar or McDonald cerclage in place \> 1 week

You may not qualify if:

  • Active labor (\> 8 uterine contractions \[UCs\] per hour)
  • Chorioamnionitis as defined by temperature \> 38 plus fetal tachycardia or uterine tenderness
  • Placenta previa or undiagnosed vaginal bleeding
  • Nonreassuring fetal status by nonstress test (NST) or biophysical profile (BPP)
  • Mature pulmonary studies
  • Positive gram stain, culture, white blood cells (WBC) \> 30, or glucose \< 14 on amniocentesis
  • Major fetal anomaly
  • Presentation \> 48 hours after rupture of membranes
  • abdominal cerclage
  • Cerclage done for symptomatic cervical dilation (cervix dilated \> 3 cm)
  • Post amniocentesis membrane rupture (rupture which occurs within one week of amniocentesis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (23)

Desert Good Samaritan Hospital

Mesa, Arizona, 85202, United States

Location

Banner Good Samaritan Hospital

Phoenix, Arizona, 85006, United States

Location

Tucson Medical Center

Tucson, Arizona, 85712, United States

Location

Saddleback Memorial Medical Center

Laguna Hills, California, 92653, United States

Location

Long Beach Memorial Medical Center

Long Beach, California, 90801-1428, United States

Location

University of Southern California-Irvine Medical Center

Orange, California, 92868, United States

Location

Good Samaritan Hospital

San Jose, California, 95124, United States

Location

Swedish Medical Center

Denver, Colorado, 80110, United States

Location

Presbyterian/St Luke's Hospital

Denver, Colorado, 80218, United States

Location

Rose Medical Center

Denver, Colorado, 80220, United States

Location

Yale New-Haven Medical Center

New Haven, Connecticut, 06504, United States

Location

University of Illinois at Chicago

Chicago, Illinois, 60612, United States

Location

Lousiana State University Health Science

Shreveport, Louisiana, 60612, United States

Location

Hutzel Women's Hospital

Detroit, Michigan, 48201, United States

Location

Saint Luke's Hospital, Kansas City

Kansas City, Missouri, 64111, United States

Location

Sunrise Medical Center

Las Vegas, Nevada, 89109, United States

Location

University of Rochester Medical Center

Rochester, New York, 14642, United States

Location

The University Hospital

Cincinnati, Ohio, 45219, United States

Location

Sacred Heart Medical Center

Eugene, Oregon, 97401, United States

Location

Erlanger Medical Center

Chattanooga, Tennessee, 37403, United States

Location

Memorial Hermann Children's Hospital-Texas Center for Fetal Assessment

Houston, Texas, 77030, United States

Location

Evergreen Hospital

Kirkland, Washington, 98034, United States

Location

Swedish Medical Center

Seattle, Washington, 98122-4307, United States

Location

Related Publications (7)

  • Treadwell MC, Bronsteen RA, Bottoms SF. Prognostic factors and complication rates for cervical cerclage: a review of 482 cases. Am J Obstet Gynecol. 1991 Sep;165(3):555-8. doi: 10.1016/0002-9378(91)90283-w.

    PMID: 1892180BACKGROUND
  • American College of Obstetricians and Gynecologists. Preterm Labor. Technical Bulletin no. 206,1995.

    BACKGROUND
  • McElrath TF, Norwitz ER, Lieberman ES, Heffner LJ. Management of cervical cerclage and preterm premature rupture of the membranes: should the stitch be removed? Am J Obstet Gynecol. 2000 Oct;183(4):840-6. doi: 10.1067/mob.2000.108870.

    PMID: 11035323BACKGROUND
  • Jenkins TM, Berghella V, Shlossman PA, McIntyre CJ, Maas BD, Pollock MA, Wapner RJ. Timing of cerclage removal after preterm premature rupture of membranes: maternal and neonatal outcomes. Am J Obstet Gynecol. 2000 Oct;183(4):847-52. doi: 10.1067/mob.2000.109039.

    PMID: 11035324BACKGROUND
  • Ludmir J, Bader T, Chen L, Lindenbaum C, Wong G. Poor perinatal outcome associated with retained cerclage in patients with premature rupture of membranes. Obstet Gynecol. 1994 Nov;84(5):823-6.

    PMID: 7936520BACKGROUND
  • Naylor CS, Gregory K, Hobel C. Premature rupture of the membranes: an evidence-based approach to clinical care. Am J Perinatol. 2001 Nov;18(7):397-413. doi: 10.1055/s-2001-18699.

    PMID: 11731894BACKGROUND
  • Galyean A, Garite TJ, Maurel K, Abril D, Adair CD, Browne P, Combs CA, How H, Iriye BK, Kominiarek M, Lu G, Luthy D, Miller H, Nageotte M, Ozcan T, Porto M, Ramirez M, Sawai S, Sorokin Y; Obstetrix Perinatal Collaborative Research Network. Removal versus retention of cerclage in preterm premature rupture of membranes: a randomized controlled trial. Am J Obstet Gynecol. 2014 Oct;211(4):399.e1-7. doi: 10.1016/j.ajog.2014.04.009. Epub 2014 Apr 12.

MeSH Terms

Conditions

Fetal Membranes, Premature RupturePreterm Premature Rupture of the Membranes

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Kimberly Maurel, RN, MSN, CNS

    Obstetrix Medical Group, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 20, 2005

Study Start

November 1, 2004

Primary Completion

November 1, 2013

Study Completion

April 1, 2014

Last Updated

December 19, 2014

Record last verified: 2014-12

Locations